OPCHOption Care Health, Inc.

Option Care Health, Inc. (NASDAQ: OPCH) | Price: $31.07 | Today's Change: +32.97%

Filed with the SEC on October 6, 2026 — 8-K (Items 1.01, 7.01, 9.01)

---

What Happened

Option Care Health filed an 8-K with the SEC on October 6, 2026, disclosing a material definitive agreement (Item 1.01), a Regulation FD disclosure (Item 7.01), and accompanying financial exhibits (Item 9.01). The filing includes Q1 FY2026 financial results showing revenues of $1.333 billion and net income of $46.7 million, or $0.28 per share (basic and diluted). The combination of a new material agreement and the concurrent release of quarterly financials marks this as a substantive, multi-part disclosure that investors should review closely.

---

Why It Matters

The headline numbers tell a constructive story: Q1 FY2026 revenue of $1.333 billion continues the momentum visible in the company's full-year FY2025 revenue of $4.302 billion, implying a solid run-rate trajectory heading into the rest of fiscal 2026. Operating income of $79.2 million on that revenue base yields an operating margin in the mid-single-digit percentage range — typical for a high-volume infusion services business, where scale and contract economics drive incremental profitability. The market's reaction has been emphatic: shares surged +32.97% on the day, suggesting the content of the material agreement disclosed under Item 1.01 — the precise terms of which are not detailed in the structured financial data provided — is what the market is most directly pricing. This filing arrived shortly after StockWatch's initiating coverage on OPCH, making the agreement and its strategic implications especially timely for investors following that research.

---

Analysis

The magnitude of today's move — nearly +33% — is extraordinary for a large-cap healthcare services name and signals the market is interpreting the Item 1.01 agreement as genuinely transformative, not merely routine. At a closing price of $31.07, OPCH is trading in the vicinity of the $32.00 price target established in StockWatch's initiating coverage published September 16, 2026, which speaks to the market rapidly repricing the stock toward — and potentially through — that level depending on intraday movements.

A few things to watch closely going forward:

• Nature and terms of the material agreement: Item 1.01 filings can cover anything from a major commercial contract to a merger agreement. The specific terms will define whether today's re-rating is durable or subject to revision as details emerge.
• Revenue run-rate sustainability: Q1 FY2026 revenue of $1.333 billion annualizes to roughly $5.3 billion, a meaningful step-up from FY2025's $4.302 billion. Investors will want to understand how much of that acceleration is organic versus tied to any new agreement or transaction.
• Margin trajectory: With operating income at $79.2 million on $1.333 billion in revenue, the operating leverage story will hinge on whether the new agreement improves, maintains, or pressures the existing margin structure.
• EPS trajectory: Basic and diluted EPS of $0.28 for the quarter is a clean, modest figure — the path to meaningful EPS expansion will depend heavily on what the new agreement unlocks operationally or financially.

This is a fast-moving situation. Investors should read the full 8-K exhibit attachments carefully, particularly the agreement text filed under Item 9.01, before drawing firm conclusions.

---

Disclaimer

This report is a news and informational summary based solely on data extracted from Option Care Health's SEC filing dated October 6, 2026, and structured financial facts provided from that filing's official XBRL data. It is not investment advice, does not constitute a solicitation to buy or sell any security, and carries no rating or price target. Past financial performance is not indicative of future results. Readers should conduct their own due diligence and consult a qualified financial adviser before making any investment decisions.

Existing Coverage

StockWatch has full coverage on OPCH, published 2026-09-16. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-10-06. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1014739/000110465926113904/tm2627097d1_8k.htm